
Scientists surprised to discover lymphatic 'scavenger' brain cells
The brain has its own inbuilt processes for mopping up damaging cellular waste—and these processes may provide protection from stroke and dementia.
May 1, 2017
0
589
Serelaxin has failed to meet the primary endpoints of the phase 3 RELAX-AHF-2 trial, according to late breaking results presented for the first time today at Heart Failure 2017 and the 4th World Congress on Acute Heart Failure.
May 1, 2017